Get the Stockscreener App
111.34
1.30%
1.43
Pre-market:
111.01
-0.33
-0.30%
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $111.34, with a volume of 898.98K.
It is up +1.30% in the last 24 hours and down -6.96% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$109.91
Open:
$110.32
24h Volume:
898.98K
Relative Volume:
1.22
Market Cap:
$13.55B
Revenue:
$2.72B
Net Income/Loss:
$254.30M
P/E Ratio:
18.72
EPS:
5.9463
Net Cash Flow:
$564.37M
1W Performance:
-7.02%
1M Performance:
-6.96%
6M Performance:
-0.61%
1Y Performance:
+26.35%
1-Day Range:
$108.54
$111.37
1-Week Range:
$107.17
$119.59
52-Week Range:
$86.30
$129.50
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| RVTY | 111.34 | 13.55B | 2.72B | 254.30M | 564.37M | 5.9463 |
| TMO | 512.84 | 195.55B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 233.10 | 166.92B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 128.57 | 36.94B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 194.38 | 35.03B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 418.61 | 33.80B | 3.84B | 866.24M | 792.60M | 9.80 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK - Business Wire
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | PKI Stock News - StockTitan
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells - BioSpace
Revvity CEO to Present Strategic Update at Evercore ISI HealthCONx Conference | RVTY Stock News - StockTitan
Scale Biosciences and Revvity's BioLegend Launch First-Of-Its-Kind Solution for High Parameter Protein Profiling of Single Cells - Marketscreener.com
Revvity updates organizational structure - Nasdaq
Revvity Announces Major Restructuring, Sets 2024 Investor Day for Strategic Update | RVTY Stock News - StockTitan
Sumitomo Mitsui Trust Group Inc. Purchases 9,473 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Impax Asset Management Group plc Sells 10,233 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Select Equity Group, L.P. Reduces Stake in Revvity Inc - GuruFocus.com
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
T. Rowe Price Investment Management, Inc. Reduces Stake in Revvi - GuruFocus.com
Janus Henderson Group PLC's Strategic Acquisition of Shares in R - GuruFocus.com
Sivik Global Healthcare LLC Purchases New Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Bretton Capital Management LLC Invests $1.41 Million in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative - Simply Wall St
Capital Research Global Investors Bolsters Position in Revvity I - GuruFocus.com
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
These Analysts Revise Their Forecasts On Revvity Following Q3 Results - MSN
FY2024 EPS Estimates for Revvity Boosted by Leerink Partnrs - MarketBeat
Revvity stock price target lifted, outperform rating on strong results By Investing.com - Investing.com Canada
Revvity Inc. stock rises Tuesday, still underperforms market - MarketWatch
TD Cowen Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Raymond James Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
TD Cowen increases Revvity stock price target, keeps buy on stable signs - Investing.com Canada
Revvity Announces Financial Results for the Third Quarter of 2024 - BioSpace
Revvity, Inc. (NYSE:RVTY) Q3 2024 Earnings Call Transcript - Insider Monkey
Revvity stock price target lifted, outperform rating on strong results - Investing.com India
Revvity beats Q3 expectations, raises full-year EPS outlook - Investing.com India
Revvity Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges - GuruFocus.com
KeyBanc maintains $132 target on Revvity amid EPS guidance raise By Investing.com - Investing.com Canada
Revvity Inc price target raised to $134 by Evercore ISI - Investing.com Canada
Q3 2024 Revvity Inc Earnings Call - Mujer es Más
Revvity Reports Strong Q3 Growth and New Share Buyback - TipRanks
Revvity Adjusts Revenue Forecast But Lifts Profit Expectations - Finimize
Earnings call: Revitty reports solid Q3 with $684 million in revenue - Investing.com
Revvity (NYSE:RVTY) Hits New 52-Week HighWhat's Next? - MarketBeat
KeyBanc maintains $132 target on Revvity amid EPS guidance raise - Investing.com
RVTY Q3 Earnings & Revenues Beat Estimates, Guidance Revised - MSN
Revvity Inc (RVTY) Shares Up 5.6% on Nov 4 - GuruFocus.com
Developing image-based T-cell assays for monitoring apoptosis and CAR expression - News-Medical.Net
Revvity climbs after raising 2024 profit forecast - XM
Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings - Yahoo Finance
Q3 2024 Revvity Inc Earnings Call Transcript - GuruFocus.com
Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters
Revvity Inc (RVTY) Q3 2024 Earnings: Revenue Hits $684M, GAAP EPS Soars to $0.77, Surpassing Estimates - GuruFocus.com
Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.69%
2.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):